CVS Health Corporation (CVS) had a weak trading session and its shares were last down at $77.97, down -0.84% or -1.07 points. The trading data also revealed that the total net flow stood at $28.4 million as the shares had $107.07 million in upticks but lost $78.67 million in downticks. The up/down ratio was 1.36. This data is particularly important for the traders and speculators alike as it could also be used to gauge the strength of the momentum in the shares. During the past week, the shares have seen a change of 0.28% in the shares.The block trade data suggests an inflow of $33.83 million in upticks and an outflow of $6.13 million in downticks. The up/down ratio for the block stood at 5.52. The net money flow for this transaction was recorded at $27.7.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
CVS Health Corporation has lost 1.91% in the last five trading days and dropped 0.59% in the last 4 weeks. CVS Health Corporation has dropped 6.73% during the last 3-month period . Year-to-Date the stock performance stands at -0.59%. CVS Health Corporation (NYSE:CVS) witnessed a decline in the market cap on Wednesday as its shares dropped 1.07% or 0.84 points. After the session commenced at $78.65, the stock reached the higher end at $79.1 while it hit a low of $77.69. With the volume soaring to 6,463,085 shares, the last trade was called at $77.97. The company has a 52-week high of $106.67. The company has a market cap of $83,150 million and there are 1,066,439,169 shares in outstanding. The 52-week low of the share price is $69.3.
Company has reported several Insider transactions to the SEC, on May 6, 2016, Larry J Merlo (President and CEO) sold 38,247 shares at 105.00 per share price.On May 6, 2016, Troyen A Brennan (EVP and Chief Medical Officer) sold 7,517 shares at 105.00 per share price.On Apr 5, 2016, Andrew Sussman (EVP & Pres, CVS MinuteClinic) sold 2,844 shares at 105.00 per share price.
CVS Health Corp Last issued its quarterly earnings results on Nov 8, 2016. The company reported $1.64 EPS for the quarter, beating the analyst consensus estimate by $ 0.07. Analyst had a consensus of $1.57. The company had revenue of $44615.00 million for the quarter, compared to analysts expectations of $45294.50 million. The companys revenue was up 15.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.29 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.CVS Health Corp was Downgraded by Jefferies to Hold on Dec 12, 2016. CVS Health Corp was Reiterated by Mizuho on Nov 9, 2016 to Buy, Lowers Price Target to $ 90 from a previous price target of $111 .
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.